Elisabetta Antonioli

Years Active: 2019-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Vincenzo Sammartano, Elisabetta Antonioli, Gabriele Buda, Sara Ciofini, Veronica Candi, Ludovica Pengue, Maria Livia Del Giudice, Irene Attucci, Francesca Bacchiarri, Ubaldo Occhini, Maria Teresa Pirrotta, Federico Perfetto, Monica Bocchia, Alessandro Gozzetti
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network). Journal of personalized medicine 12 (3) (2022)
Elisabetta Antonioli, Michela Staderini, Sofia Pilerci, Federico Perfetto, Francesco Cappelli, Marco Allinovi, Chiara Nozzoli, Irene Attucci, Alessandra Buzzichelli, Maria Messeri, Alberto Bosi
Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience. Leukemia & lymphoma 61 (13) (2020)
Elisabetta Antonioli, Arianna Fani, Benedetta Sordi, Benedetta Puccini, Alberto Bosi
Chemotherapy-related nail toxicity. International journal of hematology 110 (5) (2019)
Elisabetta Antonioli, Chiara Nozzoli, Gabriele Buda, Michela Staderini, Riccardo Boncompagni, Francesca Martini, Mario Petrini, Alberto Bosi, Riccardo Saccardi
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients. European journal of haematology 104 (2) (2019)

Elisabetta Antonioli.css-eqlu8i{font-size:small;padding-left:4px;}